An industry-wide talent development failure is exacerbating the depth of skills and critical thinking needed for future clinical trials. On top of this, there is not enough highly-experienced staff available to deliver on biopharma’s needs. Watch Parexel’s Yun Hardiman, Vice President, FSP, Audra Hodges, Associate FSP Project Director and Vaibhav Sathe, Associate Director, Statistical Programming discuss ways companies can invest in their junior-level staff to increase their knowledge and make them more marketable. They also discuss critical skills, future scenarios, and current efforts to cultivate the right competencies and novel ways to use resources more efficiently.
Be the first to comment